336 related articles for article (PubMed ID: 11342656)
1. IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance.
Sewnath ME; Olszyna DP; Birjmohun R; ten Kate FJ; Gouma DJ; van Der Poll T
J Immunol; 2001 May; 166(10):6323-31. PubMed ID: 11342656
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide binding protein is an essential component of the innate immune response to Escherichia coli peritonitis in mice.
Knapp S; de Vos AF; Florquin S; Golenbock DT; van der Poll T
Infect Immun; 2003 Dec; 71(12):6747-53. PubMed ID: 14638760
[TBL] [Abstract][Full Text] [Related]
3. In vivo role of leukocyte ADAM17 in the inflammatory and host responses during E. coli-mediated peritonitis.
Long C; Wang Y; Herrera AH; Horiuchi K; Walcheck B
J Leukoc Biol; 2010 Jun; 87(6):1097-101. PubMed ID: 20154226
[TBL] [Abstract][Full Text] [Related]
4. Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis.
Zisman DA; Kunkel SL; Strieter RM; Gauldie J; Tsai WC; Bramson J; Wilkowski JM; Bucknell KA; Standiford TJ
Shock; 1997 Nov; 8(5):349-56. PubMed ID: 9361345
[TBL] [Abstract][Full Text] [Related]
5. Urokinase-type plasminogen activator receptor plays a role in neutrophil migration during lipopolysaccharide-induced peritoneal inflammation but not during Escherichia coli-induced peritonitis.
Renckens R; Roelofs JJ; Florquin S; van der Poll T
J Infect Dis; 2006 Feb; 193(4):522-30. PubMed ID: 16425131
[TBL] [Abstract][Full Text] [Related]
6. Essential involvement of CX3CR1-mediated signals in the bactericidal host defense during septic peritonitis.
Ishida Y; Hayashi T; Goto T; Kimura A; Akimoto S; Mukaida N; Kondo T
J Immunol; 2008 Sep; 181(6):4208-18. PubMed ID: 18768878
[TBL] [Abstract][Full Text] [Related]
7. Endogenous tissue-type plasminogen activator is protective during Escherichia coli-induced abdominal sepsis in mice.
Renckens R; Roelofs JJ; Florquin S; de Vos AF; Pater JM; Lijnen HR; Carmeliet P; van 't Veer C; van der Poll T
J Immunol; 2006 Jul; 177(2):1189-96. PubMed ID: 16818777
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-18 facilitates the early antimicrobial host response to Escherichia coli peritonitis.
Weijer S; Sewnath ME; de Vos AF; Florquin S; van der Sluis K; Gouma DJ; Takeda K; Akira S; van der Poll T
Infect Immun; 2003 Oct; 71(10):5488-97. PubMed ID: 14500466
[TBL] [Abstract][Full Text] [Related]
9. Differential sensitivity to Escherichia coli infection in mice lacking tumor necrosis factor p55 or interleukin-1 p80 receptors.
Acton RD; Dahlberg PS; Uknis ME; Klaerner HG; Fink GS; Norman JG; Dunn DL
Arch Surg; 1996 Nov; 131(11):1216-21. PubMed ID: 8911263
[TBL] [Abstract][Full Text] [Related]
10. Delineation of the role of Toll-like receptor signaling during peritonitis by a gradually growing pathogenic Escherichia coli.
van 't Veer C; van den Pangaart PS; Kruijswijk D; Florquin S; de Vos AF; van der Poll T
J Biol Chem; 2011 Oct; 286(42):36603-18. PubMed ID: 21690093
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of alpha7 cholinergic receptors facilitates bacterial clearance in Escherichia coli peritonitis.
Giebelen IA; Le Moine A; van den Pangaart PS; Sadis C; Goldman M; Florquin S; van der Poll T
J Infect Dis; 2008 Sep; 198(5):750-7. PubMed ID: 18627272
[TBL] [Abstract][Full Text] [Related]
12. Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model.
Matsuda T; Freeman TA; Hilbert DW; Duff M; Fuortes M; Stapleton PP; Daly JM
Surgery; 2005 Jun; 137(6):639-46. PubMed ID: 15933632
[TBL] [Abstract][Full Text] [Related]
13. Early response cytokines and innate immunity: essential roles for TNF receptor 1 and type I IL-1 receptor during Escherichia coli pneumonia in mice.
Mizgerd JP; Spieker MR; Doerschuk CM
J Immunol; 2001 Mar; 166(6):4042-8. PubMed ID: 11238652
[TBL] [Abstract][Full Text] [Related]
14. Receptor for advanced glycation end products facilitates host defense during Escherichia coli-induced abdominal sepsis in mice.
van Zoelen MA; Schmidt AM; Florquin S; Meijers JC; de Beer R; de Vos AF; Nawroth PP; Bierhaus A; van der Poll T
J Infect Dis; 2009 Sep; 200(5):765-73. PubMed ID: 19627249
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the tissue factor/factor VIIa pathway does not influence the inflammatory or antibacterial response to abdominal sepsis induced by Escherichia coli in mice.
Weijer S; Schoenmakers SH; Florquin S; Levi M; Vlasuk GP; Rote WE; Reitsma PH; Spek CA; van der Poll T
J Infect Dis; 2004 Jun; 189(12):2308-17. PubMed ID: 15181580
[TBL] [Abstract][Full Text] [Related]
16. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis.
Malaviya R; Abraham SN
J Leukoc Biol; 2000 Jun; 67(6):841-6. PubMed ID: 10857857
[TBL] [Abstract][Full Text] [Related]
17. Accelerated clearance of Escherichia coli in experimental peritonitis of histamine-deficient mice.
Hori Y; Nihei Y; Kurokawa Y; Kuramasu A; Makabe-Kobayashi Y; Terui T; Doi H; Satomi S; Sakurai E; Nagy A; Watanabe T; Ohtsu H
J Immunol; 2002 Aug; 169(4):1978-83. PubMed ID: 12165523
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of blood components and peritoneal fluid during treatment of murine E. coli sepsis with beta-1,3-D-polyglucose derivatives. II. Interleukin 1, tumour necrosis factor, prostaglandin E2, and leukotriene B4.
Rasmussen LT; Fandrem J; Seljelid R
Scand J Immunol; 1990 Oct; 32(4):333-40. PubMed ID: 2173131
[TBL] [Abstract][Full Text] [Related]
19. Aberrant inflammation and lethality to septic peritonitis in mice lacking STAT3 in macrophages and neutrophils.
Matsukawa A; Takeda K; Kudo S; Maeda T; Kagayama M; Akira S
J Immunol; 2003 Dec; 171(11):6198-205. PubMed ID: 14634136
[TBL] [Abstract][Full Text] [Related]
20. Pivotal role of signal transducer and activator of transcription (Stat)4 and Stat6 in the innate immune response during sepsis.
Matsukawa A; Kaplan MH; Hogaboam CM; Lukacs NW; Kunkel SL
J Exp Med; 2001 Mar; 193(6):679-88. PubMed ID: 11257135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
